drugset / Trial / NCT00749099

Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum)

NCT00749099 ↗

Non-randomizedSingle-groupOpen-label

Summary

The overall purpose of this research is to demonstrate (or measure) the intestinal availability of lipase, amylase, and protease (enzymes the body has a shortage of) from PANCRECARB® when administered with a meal.

Timeline

Start
2007-04
Primary completion
2010-09
Completion
2010-09

Outcome

Outcome not reported

Stopped: “No longer required study by FDA for NDA approval.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pancrelipase Protein / enzyme biologic — —